FamiCord AG
V3V
Rank in Stocks
#22971
VITA 34 AG is dedicated to the collection, processing, and long-term storage of... VITA 34 AG is dedicated to the collection, processing, and long-term storage of stem cells derived from umbilical cord blood and tissue. Its operations span Germany, Spain, and global markets. The company actively develops a range of advanced therapeutic solutions, including cell and gene therapies, specialized cell therapeutic procedures, cryopreservation of a patient's own immune cells, and CAR-T cell technology. Furthermore, VITA 34 manufactures advanced therapy medicinal products (ATMPs) based on mesenchymal stem cells for experimental applications by specialized medical institutions. It also preserves stem cells from perinatal tissues and adult body fat, and provides contract manufacturing for pharmaceutical intermediates. Founded in 1997, VITA 34 AG is headquartered in Leipzig, Germany.
Share Price
$2.73
Last synced: 2026-11-09
Market Cap
$47.54M
Change (1 day)
-4.81%
Change (1 year)
-56.00%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade FamiCord AG (V3V)
Category
Healthcare
Operating Margin for FamiCord AG (V3V)
Operating Margin as of November 2026 TTM: -3.07%
According to FamiCord AG's latest financial reports, its current operating margin (TTM) is -3.07%. At the end of 2025 the company had an operating margin of -3.99%.
Operating Margin history for FamiCord AG from 2006 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -3.07% | -23.06% |
| 2025 | -3.99% | -64.56% |
| 2024 | -11.26% | 178.02% |
| 2023 | -4.05% | -89.26% |
| 2022 | -37.71% | 266.83% |
| 2021 | -10.28% | -186.68% |
| 2020 | 11.86% | -26.84% |
| 2019 | 16.21% | 25.76% |
| 2018 | 12.89% | 1,741.43% |
| 2017 | 0.70% | -85.39% |
| 2016 | 4.79% | -57.91% |
| 2015 | 11.38% | -7.18% |
| 2014 | 12.26% | 13.10% |
| 2013 | 10.84% | -298.90% |
| 2012 | -5.45% | 160.77% |
| 2011 | -2.09% | -147.72% |
| 2010 | 4.38% | 309.35% |
| 2009 | 1.07% | -107.05% |
| 2008 | -15.18% | 181.63% |
| 2007 | -5.39% | 0.00% |
| 2006 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -112.57% |
US
|
|
| -149.01% | -51.46% |
US
|
|
| 25.57% | -108.33% |
AU
|
|
| 31.23% | -110.17% |
BE
|
|
| 29.35% | -109.56% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about FamiCord AG's operating margin
What is FamiCord AG's operating margin?
FamiCord AG's operating margin is -3.07%, as of Nov 2026.
What was FamiCord AG's operating margin in 2025?
In 2025, FamiCord AG's operating margin was -3.99%, compared with -11.26% in 2024.
How has FamiCord AG's operating margin changed since 2020?
From 2020 to 2025, FamiCord AG's operating margin was highest in 2020 (11.86%) and lowest in 2022 (-37.71%).
How does FamiCord AG's operating margin compare with similar companies?
FamiCord AG's operating margin (-3.07%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.